Lilly Eli Aktie - LLY

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

755,20

Gebot

752,90

Fragen

757,50

Volumen

3.350

741,90 Tagesbereich 765,20

40,43 52-Wochen-Bereich 891,00

Marktkapitalisierung

716,058B

Handelsende

754,00

Handelsbeginn

754,60

Letzte Trade

757.5

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

3.992

Ausgegebene Aktien

948.169.999

Dividendenrendite

0.87%

Kurs-Gewinn-Verhältnis

73,58

Gewinn pro Aktie (EPS)

11,17

Erlöse

45,04B

Nettogewinn

10,59B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.lilly.com

Hauptsitz

Indianapolis, Indiana, USA

Gegründet

Lilly Eli and Co is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker LLY. The last closing price for Lilly Eli was 754,00 €. Over the last year, Lilly Eli shares have traded in a share price range of 40,43 € to 891,00 €.

Lilly Eli currently has 948.169.999 shares in issue. The market capitalisation of Lilly Eli is 714,92 € billion. Lilly Eli has a price to earnings ratio (PE ratio) of 73.58.

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., Feb. 25, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Eli Lilly and...

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Health Education Answers recognized as an effective online tool by eHealthcare Leadership Awards and Web Marketing Association INDIANAPOLIS, Feb...

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

CHICAGO, Jan. 22 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for BRK.B, PM, AFL, LLY, and DHI. Seven Summits Strategic...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-103	-12.0018643673	858.2	861.9	741.9	5444	792.35827853	DE
4	-81.2	-9.70827355332	836.4	891	741.9	3717	829.37449084	DE
12	15.1	2.04026482908	740.1	891	40.43	3992	783.85160099	DE
26	-84.1	-10.0202549744	839.3	891	40.43	4139	777.49085033	DE
52	85.2	12.7164179104	670	891	40.43	4646	775.1007964	DE
156	508.6	206.244931062	246.6	891	40.43	2973	657.22089739	DE
260	637.52	541.740312712	117.68	891	40.43	2174	569.49337387	DE

LLY - Frequently Asked Questions (FAQ)

What is the current Lilly Eli share price?

The current share price of Lilly Eli is 755,20 €

How many Lilly Eli shares are in issue?

Lilly Eli has 948.169.999 shares in issue

What is the market cap of Lilly Eli?

The market capitalisation of Lilly Eli is EUR 714,92B

What is the 1 year trading range for Lilly Eli share price?

Lilly Eli has traded in the range of 40,43 € to 891,00 € during the past year

What is the PE ratio of Lilly Eli?

The price to earnings ratio of Lilly Eli is 73,58

What is the cash to sales ratio of Lilly Eli?

The cash to sales ratio of Lilly Eli is 17,3

What is the reporting currency for Lilly Eli?

Lilly Eli reports financial results in USD

What is the latest annual turnover for Lilly Eli?

The latest annual turnover of Lilly Eli is USD 45,04B

What is the latest annual profit for Lilly Eli?

The latest annual profit of Lilly Eli is USD 10,59B

What is the registered address of Lilly Eli?

The registered address for Lilly Eli is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204

What is the Lilly Eli website address?

The website address for Lilly Eli is www.lilly.com

Which industry sector does Lilly Eli operate in?

Lilly Eli operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
DP8CervoMed Inc	6,25 € (192,06%)	123,89k
49QZenatech Inc	4,86 € (86,92%)	3,67k
M0YNMynaric AG	1,305 € (79,26%)	1,26M
7IPImpro Precision Industries Limited	0,478 € (61,49%)	750
D7GNel ASA	0,3199 € (61,16%)	66,72M
WIG1Wige Media AG	0,034 € (-64,77%)	1,49M
GTYGateway Real Estate AG	0,30 € (-42,31%)	30,37k
I8RIrobot Corp Dl 01	3,735 € (-35,87%)	116,47k
0S90Syros Pharmaceuticals Inc	0,0715 € (-32,55%)	68,93k
NL8Genesis Ai Corp	0,01 € (-31,51%)	205,46k
D7GNel ASA	0,3199 € (61,16%)	66,72M
UH7ATennant Minerals NL	0,0075 € (-16,67%)	3,6M
3CPXiaomi Corporation	6,20 € (-3,28%)	1,72M
TKAThyssenkrupp AG	8,71 € (2,16%)	1,71M
PUMPuma SE	22,68 € (-14,09%)	1,68M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Lilly Eli and Co (LLY)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Lilly Eli and Co

LLY Neueste Nachrichten

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

Lilly CEO Stresses Human Element in Driving Medical Innovation

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

LLY - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Lilly Eli and Co (LLY) Börsenkurse

Lilly Eli and Co (LLY)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Lilly Eli and Co

LLY Neueste Nachrichten

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

Lilly CEO Stresses Human Element in Driving Medical Innovation

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

LLY - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen